Fundamentals Data provided by Morningstar.Data provided by Morningstar.
52 Week Range
Avg. Volume (1 month)
as at 24 Feb 3:44pm
|28 Feb 2020||$0.0540||100.00%||Interim||27 Mar 2020|
|04 Sep 2019||$0.0780||100.00%||Final||02 Oct 2019|
|05 Mar 2019||$0.0800||100.00%||Interim||27 Mar 2019|
|06 Sep 2018||$0.0800||100.00%||Final||28 Sep 2018|
|01 Mar 2018||$0.0780||100.00%||Interim||23 Mar 2018|
|07 Sep 2017||$0.0800||100.00%||Final||29 Sep 2017|
|30 Sep 2016||$0.1280||100.00%||Final||07 Nov 2016|
|22 Mar 2016||$0.1280||100.00%||Interim||20 Apr 2016|
|28 Sep 2015||$0.1360||100.00%||26 Oct 2015|
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
|Date||Announcement||Price Sensitive?||Time||No. of Pages||File Size|
Estia Health Ltd (EHE) is one of Australia’s largest residential aged care providers. The company delivers care to more than 8,000 older Australians each year from its homes which are located along the eastern seaboard of Australia and South Australia.
Estia Health was established in 2014 through the merger of 3 residential aged care businesses. Despite the Estia Health share price quickly rising after listing on the ASX that very year, Estia Health shares did not enjoy such success in the latter half of the decade. Nonetheless, as an aged care provider, the company is supported by ageing population tailwinds.
|23 Jul 2021||$2.20||$0.00||0.00%||272,039||$2.20||$2.25||$2.18|
|22 Jul 2021||$2.20||$-0.02||-0.90%||225,021||$2.23||$2.25||$2.20|
|21 Jul 2021||$2.22||$0.01||0.45%||373,039||$2.22||$2.26||$2.19|
|20 Jul 2021||$2.21||$-0.04||-1.78%||182,500||$2.25||$2.28||$2.21|
|19 Jul 2021||$2.25||$-0.05||-2.17%||253,043||$2.26||$2.29||$2.23|
|16 Jul 2021||$2.30||$0.01||0.44%||238,295||$2.29||$2.33||$2.27|
|15 Jul 2021||$2.29||$-0.06||-2.55%||163,496||$2.32||$2.35||$2.29|
|14 Jul 2021||$2.35||$0.02||0.86%||205,607||$2.33||$2.35||$2.31|
|13 Jul 2021||$2.33||$0.06||2.64%||439,555||$2.27||$2.34||$2.27|
|12 Jul 2021||$2.27||$-0.06||-2.58%||344,447||$2.34||$2.34||$2.25|
|09 Jul 2021||$2.33||$-0.01||-0.43%||145,988||$2.37||$2.37||$2.31|
|08 Jul 2021||$2.34||$-0.08||-3.31%||298,131||$2.42||$2.42||$2.33|
|07 Jul 2021||$2.42||$0.10||4.31%||293,371||$2.33||$2.42||$2.32|
|06 Jul 2021||$2.32||$-0.05||-2.11%||327,096||$2.35||$2.37||$2.30|
|05 Jul 2021||$2.37||$-0.02||-0.84%||660,005||$2.38||$2.40||$2.34|
|02 Jul 2021||$2.39||$-0.05||-2.05%||196,916||$2.43||$2.44||$2.39|
|01 Jul 2021||$2.44||$-0.03||-1.21%||162,128||$2.47||$2.52||$2.44|
|30 Jun 2021||$2.47||$0.00||0.00%||610,666||$2.45||$2.52||$2.42|
|29 Jun 2021||$2.47||$-0.06||-2.37%||300,153||$2.50||$2.50||$2.44|
|28 Jun 2021||$2.53||$-0.03||-1.17%||353,851||$2.53||$2.57||$2.47|
|25 Jun 2021||$2.56||$0.06||2.40%||407,599||$2.50||$2.60||$2.49|
|09 Dec 2020||Ian Thorley||Issued||621||$1,099,334||
Issue of securities. 1,088,009 - performance rights
|10 Nov 2020||Gary Weiss||Buy||30||$41,088||
|11 Sep 2020||Ian Thorley||Expiry||100||$145,461||
As advised by the company. Lapse of long term performance rights.
466,916 - performance rights.
|11 Sep 2020||Norah Barlow||Expiry||222||$322,970||
As advised by the company. 103,883 - Performance Rights
Lapse of FY18 LTIs.
|21 Aug 2020||Warwick Smith||Buy||65||$101,250||
|Dr Gary Hilton Weiss||Non-Executive DirectorNon-Executive Chairman||Feb 2016||
Dr Weiss has international business experience and has been involved in numerous cross-border mergers and acquisitions. Dr Weiss is Chairman of Ridley Corporation Limited and Ardent Leisure Group Limited, Executive Director of Ariadne Australia Limited, and a Director of several other public companies including Thorney Opportunities Limited, Hearts and Minds Investments Limited and The Straits Trading Company Limited. Dr Weiss is also a Commissioner of the Australian Rugby League Commission and a Director of the Victor Chang Cardiac Research Institute. Dr Weiss was Chairman of Clearview Wealth Ltd from 2013 to May 2016, Executive Director of Guinness Peat Group plc from 1990 to April 2011 and has held directorships of numerous companies, including Tag Pacific Limited, Pro-Pac Packaging Limited, Coats Group plc (Chairman), Premier Investments Ltd, Westfield Group, Tower Australia Limi, Australian Wealth Management Limited, Tyndall Australia Limited (Deputy Chairman), Joe White Maltings Limited (Chairman), CIC Limited, Whitlam Turnbull & Co Limited and Industrial Equity Limited. Dr Weiss has authored numerous articles on a of legal and commercial topics.
|Mr Ian Thorley||Chief Operating OfficerChief Executive OfficerManaging Director||Nov 2018||
Mr Thorley has over 30 years health and aged care experience in both Australia and overseas. Appointed as Chief Executive Officer in October 2018, Mr Thorley was previously Estia Health's Chief Operating Officer from October 2016, where he was responsible for leading Estia's operations and care teams,. embedding key improvements resulting in revenue growth and operational efficiencies, while delivering consistently high standards of quality care to residents across a growing portfolio of homes. Mr Thorley's executive experience includes CEO and COO roles in aged care groups, acute private hospital groups and diagnostic services. Mr Thorley has been at the forefront of developments that have shaped Australia's healthcare sector, including the privatisation of public hospitals, new reimbursement and funding models, and a range of public/private sector service models. Mr Thorley has held the position of Non-executive Director in private equity owned, and ASX listed companies and has consulted to aged care operators, private hospital groups, health insurers, health logistics and specialist health recruitment businesses throughout Australia.
|Ms Helen Kurincic||Non-Executive Director||Jul 2017||
Ms Kurincic has executive and Non-executive experience across the healthcare sector. Ms Kurincic is Chairman of Integral Diagnostics Limited, and a Non-executive Director of HBF Health Limited and McMillan Shakespeare Limited. Ms Kurincic was previously the Chief Operating Officer and Director of Genesis Care for seven years from early inception in 2007, creating Australia's radiation oncology and cardiology service business. Previous roles also include Non-executive Director of Sirtex Medical Limited, Non-executive Director of DCA Group Limited which included residential aged care in Australia and New Zealand, Non-executive Director of AMP Capital Investor's aged care business Domain Principal Group, CEO and Executive Director of residential aged care provider Benetas and Board Member of Melbourne Health and Orygen Research Centre. Ms Kurincic has also been actively involved in healthcare government policy reform across various areas of the healthcare sector.
|Ms Karen Lee Collett Penrose||Non-Executive Director||Oct 2018||
Ms Penrose is an experienced Company Director who has served as a Non-executive Director on the boards of ASX listed companies in financial services, resources, aged care and infrastructure sectors for the past five years. Karen's executive career was in leadership and CFO roles, mainly in financial services. She is passionate about customer outcomes, financial management and well-versed in operating in a rapidly changing regulatory environment. Karen is a Director and Chair of the Audit Committee of Bank of Queensland, Spark Infrastructure RE Limited and Vicinity Centres. She is also Deputy Chairman of Marshall Investments. Karen is a Member of Chief Executive Women and Women Corporate Directors.
|Hon Warwick Leslie Smith||Non-Executive Director||May 2017||
Mr Smith is Chairman of the Advisory Board of Australian Capital Equity, which has significant interests in media, entertainment, research and technology development, as well as property and industrial activities. He is a Director of Seven Group Holdings, a Australian operating and investment group with market businesses and investments in industrial services, oil and gas, and media, Chairman of the Australia-China Council and newly announced Chairman-designate of the National Foundation for Australia-China Relations and Chairman of the China Leadership Group of the Business Council of Australia. In addition, he is Global Trustee of the Asia Society and Chairman Emeritus of the Asia Society in Australia. Formerly, he was Chairman of E*TRADE, Chairman New South Wales & Australian Capital Territory and Senior Managing Director of the Australia New Zealand Banking Group Limited (ANZ), Chairman, ANZ Thailand and Director, ANZ Greater China. He was an Executive Director with Macquarie Bank for 10 years and an Australian Federal Government Minister, with a parliamentary career spanning 15 years, including Minister for Family Services and Aged Care. He was also Australia's first Telecommunications Ombudsman and has received a Centenary Medal and has twice been awarded an Order of Australia.
|Ms Norah Kathleen Barlow||Non-Executive Director||Nov 2014||
Ms Barlow is amongst Australasia's experienced and respected executives and directors, with an knowledge of the aged and health care sector. Mrs Barlow has a background across business leadership and management, strategy, corporate finance, governance, tax and accounting. Mrs Barlow is a Member of the National Advisory Council on the Employment of Women, was President of the Retirement Villages Association (NZ) for seven years and made an Officer of the New Zealand Order of Merit for services to business in 2014. Mrs Barlow was also a Non-executive Director of Ingenia Communities Group and chair of the Audit Committee for Methven Limited. Mrs Barlow stepped down as CEO of Estia in November 2018 and remains on the board as a Non-executive Director. Mrs Barlow is currently Chief Executive of Heritage Lifecare.
|Mr Paul Foster||Non-Executive Director||Feb 2016||
Mr Foster is an experienced financial services professional and Company Director, with more than 20 years investment experience in the infrastructure, private equity and real estate asset classes, including investments in the healthcare sector. Mr Foster is a Managing Director at Pacific Equity Partners, one of Australia's alternative investment management firms. Mr Foster is also an alternate Director of Intellihub Holdings Pty Ltd. Until May 2015, he was head of AMP Capital's Infrastructure investment business in Australia and New Zealand, where he was responsible for the management of $4.5 billion of infrastructure investments on behalf of Australian and superannuation funds and investors. In this role, and amongst investments spanning the aged care, transport, timberland and social infrastructure sectors, Mr Foster was responsible for the investment that created the second for profit aged care business in Australia. Mr Foster was a Director of the Opal Aged Care Group (formerly Domain Principal Group) between 2010 and 2015 and was Chairman of the Group in 2011. Prior to AMP Capital, Mr Foster was an investment professional at Macquarie Bank Group and Perpetual Investments.
|Ms Leanne Ralph||Company Secretary||Apr 2019||
|Leanne Ralph||Company Secretary||
|J P Morgan Nominees Australia Pty Limited||48,573,684||18.59%|
|HSBC Custody Nominees (Australia) Limited||48,494,223||18.56%|
|Citicorp Nominees Pty Limited||29,342,977||11.23%|
|Network Investment Holdings Pty Ltd||24,665,858||9.44%|
|Argo Investments Limited||11,809,250||4.52%|
|Bnp Paribas Noms Pty Ltd (Drp)||10,163,523||3.89%|
|Bnp Paribas Nominees Pty Ltd (Agency Lending Drp A/C)||4,900,143||1.88%|
|National Nominees Limited||4,364,029||1.67%|
|3Rd Wave Investors Pty Ltd||4,250,000||1.63%|
|Emalyn Holdings Pty Limited (John Kennedy A/C)||4,102,766||1.57%|
|Network Investment Holdings Pty Ltd I||2,580,000||0.99%|
|Buttonwood Nominees Pty Ltd||1,966,253||0.75%|
|Mr Mark Edward Kennedy (Mark Edward Kennedy A/C)||1,910,678||0.73%|
|Custodial Services Limited (Beneficiaries Holding A/C)||1,890,035||0.72%|
|Mark Edward Kennedy (Mark Edward Kennedy Family)||1,277,438||0.49%|
|Kennbros Pty Limited||1,156,834||0.44%|
|Riviera Health Pty Ltd (Manken Family Super A/C)||936,278||0.36%|
|National Nominees Limited (Db A/C)||818,109||0.31%|
|Woodross Nominees Pty Ltd||688,000||0.26%|
|Sep Super Pty Ltd (Sep Super Fund A/C)||480,920||0.18%|
Estia Health typically pays twice yearly, fully franked dividends in late March and either late September or early October each year. Most recently, Estia paid its interim dividend of 5.4 cents per share on 23 March 2020.
Yes. Estia Health offers shareholders residing in Australia and New Zealand the option of either full or partial participation in its dividend reinvestment plan. Shareholders residing in other jurisdictions may also be eligible to participate under certain circumstances. The Estia Board may, at any time, determine that the DRP will not apply to a particular dividend payment by making an announcement to the market.